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Abstract
Staphylococcus aureus initiates infections and produces virulence factors, including superantigens (SAgs), at mucosal
surfaces. The SAg, Toxic Shock Syndrome Toxin-1 (TSST-1) induces cytokine secretion from epithelial cells, antigen
presenting cells (APCs) and T lymphocytes, and causes toxic shock syndrome (TSS). This study investigated the mechanism
of TSST-1-induced secretion of proinflammatory cytokines from human vaginal epithelial cells (HVECs) and determined if
curcumin, an anti-inflammatory agent, could reduce TSST-1-mediated pathology in a rabbit vaginal model of TSS. TSST-1
caused a significant increase in NF-kB-dependent transcription in HVECs that was associated with increased expression of
TNF- a, MIP-3a, IL-6 and IL-8. Curcumin, an antagonist of NF-kB-dependent transcription, inhibited IL-8 production from ex
vivo porcine vaginal explants at nontoxic doses. In a rabbit model of TSS, co-administration of curcumin with TSST-1
intravaginally reduced lethality by 60% relative to 100% lethality in rabbits receiving TSST-1 alone. In addition, TNF-a was
undetectable from serum or vaginal tissue of curcumin treated rabbits that survived. These data suggest that the
inflammatory response induced at the mucosal surface by TSST-1 is NF-kB dependent. In addition, the ability of curcumin to
prevent TSS in vivo by co-administration with TSST-1 intravaginally suggests that the vaginal mucosal proinflammatory
response to TSST-1 is important in the progression of mTSS.
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Introduction
Staphylococcus aureus is a significant human pathogen that causes a
wide range of diseases, including menstrual toxic shock syndrome
(mTSS). Staphylococcal mTSS is an acute-onset, potentially fatal,
multi-system illness characterized by fever, hypotension, sunburn-
like rash, peeling of the skin upon recovery, and multi-organ
dysfunction [1–3]. The staphylococcal superantigen (SAg), Toxic
Shock Syndrome Toxin-1 (TSST-1), causes the majority of mTSS
cases by penetrating the vaginal mucosa and non-specifically cross-
linking Major Histocompatibility Complex (MHC) class II
molecules with T-cell receptors (TCR) causing massive systemic
cytokine release from T cells (IL-2, TNF-b, and IFN-c) and
macrophages (IL-1b and TNF-a). However, the initial effects of S.
aureus TSST-1 on the vaginal mucosa, and the outcomes of these
initial effects, which lead to mTSS are unclear and are the focus of
this study.
SAgs, including TSST-1, induce changes in cellular morphol-
ogy and secretion of proinflammatory cytokines/chemokines from
vaginal, bronchial, nasal, and intestinal epithelial cells [4–7]. The
proinflammatory effect of TSST-1 on vaginal epithelial cells may
be critical to mTSS progression as glycerol monolaurate (GML), a
non-specific anti-inflammatory agent, protected against TSS in a
rabbit vaginal model [8,9]. However, the vaginal epithelial cell
proinflammatory signaling pathways activated in response to
TSST-1 are unknown.
Staphylococcal Enterotoxin (SE)C 1, another SAg, induces
cytokine production via an NF-kB-dependent mechanism in
human peripheral blood mononuclear cells (PBMCs) [10]. NF-
kB regulates the expression of many genes, including growth
factors, cytokines, chemokines, and cell adhesion molecules in
response to external stimuli [11–13]. Many of the vaginal
epithelial genes that are upregulated in response to TSST-1 are
known NF-kB-regulated genes [11]. We hypothesized the NF-kB
pathway was critical for the epithelial proinflammatory response to
TSST-1. Blocking this pathway and inhibiting the production of
epithelial cytokines would prevent progression to mTSS [4,5,7].
Curcumin, a component of the Indian spice Turmeric (Curcuma
longa), was demonstrated to be effective in reducing the
inflammatory response and negative consequences of bacterial
infections in vitro and in vivo [14–21]. The mechanism by which
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32813curcumin mediates these effects is thought to be via inhibition of
multiple proinflammatory pathways including NF-kB.
We investigated the effects of TSST-1 on immortalized human
vaginal epithelial cells (HVECs). Our findings demonstrate that
TSST-1 causes an increase in NF-kB -dependent reporter
transcription in HVECs suggesting that NF-kB is a component
of the TSST-1-induced signaling pathway. We further explored
the ability of curcumin, to prevent TSS in a rabbit model of mTSS
[15,22]. Intravaginal co-administered curcumin and TSST-1
prevents TSS in a rabbit model potentiated with LPS. Together,
these data suggest that the inflammatory response induced at the
mucosal epithelia by TSST-1 is a critical step in the progression of
TSS. Our curcumin data indicate a role for compounds that
inhibit local mucosal epithelial cytokine and chemokine produc-
tion in the prevention of SAg-related diseases.
Results
A previous study reported an increase in the production of
cytokines/chemokines by HVECs in response to TSST-1,
including CCL20 (MIP-3a), CXCL1, CXCL2, CXCL3, IL-1b,
IL-6, IL-8, and TNF-a [4]. We hypothesized that vaginal mucosal
proinflammatory cytokines contribute to TSS by an outside-in
proinflammatory signaling mechanism, which ultimately disrupts
the mucosa and allows TSST-1 to penetrate into the submucosa
and bloodstream.
TSST-1 induces cytokines and chemokines and activates
the NF-kB pathway
Previous studies were expanded using an unrelated, immortal-
ized HVEC line constructed from another woman, which was
obtained from American Type Culture Collection (ATCC) [23].
HVECs were exposed to increasing concentrations of TSST-1
(10–500 mg/ml) for 6 h, whereupon HVEC viability or secreted
IL-8 were determined (Fig. 1 A and B). TSST-1 had minimal
effect on HVEC viability with $75% of HVECs remaining viable
following 6 h exposures of 10 to 500 mg/ml. IL-8 secretion by
HVECs maximized at TSST-1 250 mg/ml, with an estimated half
maximal effective concentration (EC50) of 100 mg/ml.
Confluent HVECs exposed to TSST-1 (50 or 100 mg/ml) for
6 h produced multiple proinflammatory cytokines/chemokines.
Changes in gene transcription were measured by collecting total
cellular RNA and conducting real time RT-PCR. Transcription of
cytokines and chemokines was upregulated 1.5 to 12 fold over 6 h
in response to TSST-1 compared to media controls (Fig. 2 A).
Multiplex cytokine array of HVEC supernates measured IL-6, IL-
8, MIP-3a, and TNF-a, which were significantly upregulated in a
dose dependent manner in response to TSST-1 (Fig. 2 B–E).
Transcription and protein expression correlated, as IL-6, IL-8,
MIP-3a, and TNF-a were upregulated in both assays.
Since HVEC cytokines were upregulated in response to TSST-
1, the NF-kB pathway was investigated as a possible downstream
effector of TSST-1 signaling. NF-kB-responsive luciferase report-
ers measured NF-kB activation in response to TSST-1 or IL-1b
(positive control) [24]. TSST-1 induced a significant increase of
.50% in NF-kB–dependent transcription compared to media
alone at 4 h (Fig. 3). IL-1b induced a significant increase of 80% in
NF-kB activity compared to media only. No luciferase activation
was detected in cells transfected with a negative control plasmid
with a minimal promoter, indicating the observed luciferase
activity was NF-kB-dependent. There was a significant increase in
NF-kB activity in HVECs transfected with the negative control
reporter when treated with IL-1b. This activation was attributed
to IL-1b activating the minimal promoter that the negative control
reporter contains. This activation was small and not seen when
stimulated with TSST-1. These data are consistent with NF-kB
activation by HVECs in response to TSST-1.
Curcumin is non-toxic to vaginal mucosa and inhibits IL-8
production
Because TSST-1 activates and NF-kB reporter and induces
NF-kB –regulated cytokines in HVECs, curcumin, a known NF-
kB inhibitor, was evaluated for its potential to reduce cytokine
production and prevent TSS. A full thickness ex vivo porcine
vaginal mucosal model was used to evaluate curcumin’s toxicity
and potential to reduce proinflammatory cytokine production.
Porcine mucosa provides an excellent tissue model for in vitro
correlates of the effects of infectious and chemical entities on
Figure 1. TSST-1 induces IL-8 and activates NF-kB from HVEC
with minimal toxicity. HVEC were exposed to TSST-1 (10–500 mg/ml)
for 6 h, then cell viability (A) and IL-8 production (B) were determined.
Viability was determined using an MTT assay. IL-8 was measured from
culture supernatants by ELISA and expressed as fold increase in IL-8
production compared to media only control (TSST-1 0 mg/ml). Data
presented are representative of three independent experiments done in
triplicate, mean 6 SD. * denotes p,0.05 compared to media only
control.
doi:10.1371/journal.pone.0032813.g001
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(60–1350 nmol/explant) for 18 h and cell viability was measured
using an MTT assay. No reduction in viability at any dose was
noted when compared to controls (Fig. 4 A). Curcumin was tested
for its ability to inhibit staphylococcal exoprotein-induced IL-8 in
the ex vivo porcine vaginal mucosa. Porcine vaginal mucosal
explants were exposed for 1 h to filtered S. aureus (MNPE)
overnight supernates, which contained SAgs (TSST-1 and SEC),
cytolysins, and proteases for maximal mucosal stimulation.
Curcumin was then applied and explants were incubated for an
additional 6 h (Fig. 4 B). Curcumin inhibited IL-8 production in
response to S. aureus exoproteins with doses as low as 14 nmoles of
curcumin per tissue explant. The IC50 in this experiment was
estimated to be 10 nmol. Higher doses of curcumin resulted in
additional decreases in IL-8 levels below those of untreated
controls.
Figure 2. TSST-1 induces cytokines from immortalized HVEC. HVECs were exposed to TSST-1 (50 and 100 mg/ml) or media only controls
(0 mg/ml) for 6 h, then RNA was harvested and supernates collected. (A) changes in expression of proinflammatory genes were measured by real time
RT-PCR, and (B–E) secreted cytokines were measured via multiplex cytokine array. Data presented in 2A are representative of three independent
experiments conducted in triplicate, data presented in 2B–E are from one experiment conducted in triplicate, mean 6 SD. * denotes p,0.05
compared to media only control.
doi:10.1371/journal.pone.0032813.g002
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A previously described rabbit vaginal model of TSS was utilized
to determine if curcumin applied vaginally could prevent TSST-1-
induced mortality [26–28]. TSST-1 was administered vaginally
via a catheter with or without curcumin (1.62 mmol) (8 rabbits per
group). Curcumin protected 5 of the 8 rabbits from TSS and death
over approximately 3 days compared to 0 of 8 positive control
animals (Fig. 5 A). This reduction in mortality was significant (p
value,0.0028, Log-rank test). Four rabbits given curcumin only
(no TSST-1 or LPS) displayed no signs or symptoms of disease and
survived the entirety of the experiment.
At the time of death or when found dead the next morning,
serum and vaginal tissue were harvested to determine levels of
TNF-a, as this is a principal cytokine that mediates hypotension in
TSS and causes death [29]. TNF-a in the serum was detected in 8
of 11 rabbits that died during the experiment, while none of the
rabbits that survived had detectable serum TNF-a (Fig. 5 B). TNF-
a was detectable in the vaginal tissue in 5 of 11 rabbits that died
during the experiment (all 5 had detectable amounts of serum
TNF-a) (Fig. 5 C). Rabbits that survived did not have detectable
vaginal TNF-a. Curcumin concentrations were quantified to
determine curcumin persistence in the vaginal tissue after
intravaginal administration. Seven of 8 treated rabbits had
detectable curcumin in the vaginal tissue at the time of death or
completion of the study. At 70 h post curcumin application, 0.8%
of the original dose remained. Curcumin was undetectable in all
serum and liver tissue samples (data not shown).
Discussion
The importance of a vaginal mucosal outside-in proinflamma-
tory signaling mechanism has been suggested to be critical to
disease progression for staphylococcal SAg-mediated TSS [30].
This mechanism is similar to the vaginal transmission of simian
immunodeficiency virus (SIV) in a rhesus macaque (Macacca
mulatta) model [31–33]. In these diseases, toxins or antigens
activate vaginal epithelial cells to produce proinflammatory
cytokines/chemokines, which disrupt the epithelium and attract
neutrophils, APCs, and T lymphocytes. This immune cell
migration in turn provides the necessary host cell targets to cause
and perpetuate disease in the presence of either SAgs or SIV.
HVECs exhibit a proinflammatory response to TSST-1 including
the increased production of cytokines/chemokines [4].
In a previous study, we demonstrated that the initial localized
mucosal inflammatory response to TSST-1 is critical for TSS
progression [4]. The proinflammatory response and progression to
TSS are abrogated by a mutation in a HVEC proinflammatory
residue of TSST-1 (D130A) [33]. This residue is located in a 12-
amino acid region, which is separate from the MHC class II
molecule and TCR binding domains, and is critical for the
induction of proinflammatory cytokines from HVECs [33,34].
TSST-1 D130A is unable to induce cytokines from HVECs and is
non-lethal when administered vaginally in the same rabbit TSS
model used in the current study. However, this mutant toxin
maintains its ability to cause disease when administered systemically
[33]. These data indicate that local mucosal effects are critical for
TSST-1 to cause systemic disease and underscore the need for an
in-depth analysis of the epithelial response to TSST-1 and other
SAgs in order to appreciate the role the epithelium plays in the
initiation of disease and how we might better prevent these diseases.
The mechanisms of SAg stimulation of cytokines from epithelial
cells are not well characterized. In this study, we observed a
proinflammatory response induced by TSST-1 from an immortalized
HVEC line obtained from ATCC and determined that the
transcription factor NF-kB is activated in HVECs in response to
TSST-1.The activation of NF-kB is likely responsible for the observed
cytokine production as many of the TSST-1-induced cytokines are
known to be regulated by NF-kB [11]. These cytokines/chemokines
are responsible for migration of immune cells to the vaginal mucosa
[ 3 5 , 3 6 ] .P r o g r e s s i o no fm T S So c c u r sa st h e s ei m m u n ec e l l sa r e
activated in a non-antigen specific manner by the superantigenic
property of TSST-1. The receptor(s) and signaling pathway(s)
responsible for the TSST-1-induced cytokine response in HVECs
remain poorly characterized and are currently under investigation.
The importance of the inflammatory response at mucosal
interfaces suggests that local anti-inflammatory compounds may
be of use in the prevention of disease. Curcumin is a component of
the Indian spice Turmeric (C. longa) that has anti-inflammatory,
anti-angiogenesis, and antimicrobial properties [14–16]. Curcu-
min was chosen as a potential anti-TSS agent because it is known
to block cytokine-mediated NF-kB activation and proinflamma-
tory gene expression by inhibiting inhibitory factor I-kB kinase
activity [15,22,37]. In addition, the proinflammatory effects of
SAgs on immune cells, such as SEA- and SEB-induced cytokine
production from PBMCs and SE-induced fever in rabbits, are
inhibited by curcumin [38].
Inhibition of IL-8 production by curcumin from ex vivo porcine
vaginal explants indicates that curcumin is anti-inflammatory at
the mucosal surface. The doses effective in reducing IL-8 were far
lower than doses that are toxic to the tissue, suggesting a wide
therapeutic window. Curcumin significantly decreased TSST-1-
induced lethality in rabbits by 60% suggesting that inhibition of
inflammation at the mucosal surface has therapeutic potential.
TNF-a, a major mediator of TSS [1–3], was undetectable from
serum or vaginal tissue of surviving curcumin-treated rabbits.
The dose of curcumin used in the rabbit model (530 nmol/cm
2)
was higher than the minimum effective dose in the full thickness
Figure 3. TSST-1 activates NF-kB in HVEC. HVECs were transfected
with plasmids containing NF-kB response elements or a basal promoter
(negative control), which control expression of luciferase. Transfected
cells were then treated with TSST-1 (250 mg/ml) or left untreated for
4 h, then luciferase activity was measured. Data presented are from 15
replicates obtained from three independent experiments, mean 6 SD.
* denotes p,0.001 compared to corresponding media only control.
doi:10.1371/journal.pone.0032813.g003
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2) but lower than
the highest dose tested in the porcine tissue toxicity experiment
(1350 nmol or 17,000 nmol/cm
2). In other words, the in vivo
rabbit experiment was performed using a concentration of
curcumin within the therapeutic range identified using the porcine
ex vivo model. Therefore, we believe that curcumin concentrations
in this range are safe for topical vaginal application.
Curcumin has previously been shown to reduce inflammation.
For example, orally administered curcumin inhibited Klebsiella
pneumoniae-induced neutrophil infiltration into lung tissue and local
TNF-a production and diminished the production of proinflam-
matory proteins in a murine lung model of infection [20]. This
reduction in inflammation and related cytokines occurs without
reduction in bacterial load indicating that the reduction in
inflammation is a result of curcumin’s anti-inflammatory activity
not any anti-microbial properties. These data in addition to our
current findings suggest that curcumin’s ability to inhibit the
proinflammatory effects of an infectious or toxigenic agent on a
mucosal surface may reduce or prevent clinical disease.
The rabbit vaginal TSS model is not without limitations,
including the LPS enhancement of TSST-1, which causes 100%
mortality in the animals by 24 h. This clearly allows for
delineation of curcumin effectiveness (survival at 24 h); however,
since many of the animals died within 6 to 12 h of TSST-1
exposures, the short exposure time limited our ability to observe
significant histological changes in the mucosa, including the
infiltration of immune cells due to exposure to TSST-1.
The findings presented here demonstrate the importance of
local inflammation caused by superantigens in the progression to
TSS. Additionally, curcumin was identified as a potential
compound for the prevention of mTSS. Based on similarities in
the proinflammatory response induced by other SAgs from
epithelial cells derived from multiple tissues [4–7], we predict that
curcumin will inhibit the proinflammatory response in these
models as well. Curcumin may thus have the potential to prevent
other SAg-mediated diseases such as atopic dermatitis, staphylo-
coccal food-borne disease, and non-menstrual TSS [39], all of
which initiate as a local proinflammatory response. We hypoth-
esize that administration of topical anti-inflammatory agents such
as curcumin would prevent this proinflammatory response,
thereby preventing progression to clinical symptoms.
Materials and Methods
Toxin purification and quantification
TSST-1 was purified by an established method using successive
thin layer isoelectric focusing [40,41]. TSST-1 (1 mg/ml), thus
prepared, contained no detectable LPS, as tested by Limulus assay
(Sigma, St. Louis, Mo.) nor were peptidoglycan, lipoteichoic acid,
hemolysin, protease, or lipase (,1 part per 10
6) detectable by
combinations of bioassay and SDS-PAGE. Comparable results
were obtained with multiple batches of TSST-1.
Human vaginal epithelial cells
HVECs were purchased from ATCC (Manassas, VA) (CRL
2616) and have been previously described [42]. This cell line was
Figure 4. Curcumin inhibits S. aureus exoprotein-induced IL-8.
(A) Porcine vaginal explants (5 mm) were treated with curcumin in 5 ml
of 100% DMSO and incubated for 18 h. Tissue viability was measured
using a MTT assay and normalized to tissue left untreated (media only:
no DMSO or curcumin). * denotes p,0.05 compared to vehicle control
(0 nmol curcumin in 100% DMSO) by ANOVA. Curcumin inhibits IL-8
production. Porcine vaginal explants were left unstimulated (B) or
stimulated with filtered S. aureus culture supernates for 1 h (C) and then
exposed to curcumin (5 ml/explant in 10% DMSO) and incubated for an
additional 6 h. Tissue was disrupted and IL-8 was measured by ELISA.
* denotes p,0.05 compared to vehicle control (0 nmol curcumin in
10% DMSO) by ANOVA. Data presented are representative of three
independent experiments done in triplicate, mean 6 SD.
doi:10.1371/journal.pone.0032813.g004
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premenopausal woman and transformed with the E6/E7 genes
of human papilloma virus 16. HVECs were cultured in
keratinocyte serum-free medium (KSFM) (Gibco, Invitrogen,
Carlsbad, CA) on plastic at 37uCi n7 %C O 2, and supplemented
with bovine pituitary extract and epidermal growth factor (as
provided by the manufacturer), calcium chloride (0.4 mM),
penicillin (50 IU/ml), streptomycin (50 mg/ml), and amphotericin
B (2.5 mg/ml) (Fungizone; Gibco, Invitrogen).
Cytokine assays
HVECs were grown to confluence in six well plates and then
exposed to purified TSST-1 (10–500 mg/ml) for 6 h in KSFM
without antibiotics. Control wells of HVECs contained KSFM
without antibiotics and without TSST-1. For some experiments
IL-8 was measured as a marker cytokine; cell culture supernates
were collected and tested for IL-8 by ELISA (R & D Systems,
Minneapolis, MN) according to manufacturer directions. Unless
otherwise specified, all experiments were conducted in triplicate,
and graphs represent means 6 standard deviation (SD).
In other experiments, supernates were removed and saved for
measuring secreted cytokines using the Luminex (Austin, TX)
multiplex assay, and human specific Fluorokine MAP multiplex
assay kits (R & D Systems, Minneapolis, MN). Lower limits of
detection: TNF-a 1.0 pg/ml, IL-8 & IL-6 0.5 pg/ml, and MIP-3a
0.47 pg/ml. Total RNA was isolated using RNeasy Mini kit
(Qiagen, Valencia, CA), and cDNA was generated using reverse
transcription (iScript, Bio-Rad Corporation) following the manu-
facturer’s instructions. Expression of cytokine genes was measured
using real time RT-PCR with SYBRH AdvantageH Premix
Figure 5. Curcumin reduces TSST-1-induced death in a rabbit model of TSS. (A) Curcumin protects rabbit from lethal TSS. TSST-1 (10 mg) in
3% DMSO was administered intravaginally with or without curcumin (1.62 mmol) (n=8 rabbits per group). Four hours later LPS (0.1 mg/kg) was
administered via ear marginal vein and animals monitored for survival. Curcumin significantly reduced TSS-induced mortality compared to untreated
(p,.0028, Log-rank test). Four rabbits (given curcumin only, triangles) displayed no signs of disease and survived the entirety of the experiment.
Curcumin decreases TNF-a in serum (B) and vaginal tissue (C) from surviving rabbits in a lethal model of TSS. TNF-a in serum and homogenized
vaginal tissue was determined using ELISA. Each data point corresponds to data from 1 rabbit measured in duplicate. Data presented as mean 6 SEM.
doi:10.1371/journal.pone.0032813.g005
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TM iCycler (Bio-Rad
Corporation). Expression of cytokine genes was normalized using
expression of the human hypoxanthine phosphoribosyltransferase
(HPRT) gene in untreated samples as a control with use of primers
listed in Table 1 (the DD
CT method).
Cell viability assay
Cell survival was measured per manufacturer instructions after
6 h exposure to TSST-1 using CellTiter 96HAqueous One
Solution Cell Proliferation Assay (Promega, Madison, WI).
NF-kB activation assay
HVECs were seeded in KSFM with antibiotics and growth
factors into 96-well plates at 15,000 cells/well. After 24 h, cells
were transfected with NF-kB luciferase reporter, negative control,
or positive control plasmids (SA Biosciences, Frederick, MD) using
the Genejuice transfection reagent (EMD4 Biosciences, Gibbs-
town, NJ). After 48 h, the cells were stimulated with 50 ng/ml IL-
1b (Biolegend), 250 mg/ml TSST-1, or were left unstimulated.
After 4 h, the level of NF-kB activation was determined using the
Dual-Glo luciferase assay (Promega, Madison, WI) and a Beckman
Coulter LD400 luminometer.
Ex vivo porcine vaginal mucosa culture
Specimens of normal porcine vaginal mucosa were excised from
animals at slaughter and transported to the laboratory to be
processed as previously described [43]. The explants were then
placed mucosal side up on a PET track-etched 0.4 mm cell culture
insert (BD Bioscience, Franklin Lakes, NJ) in 6-well plates
containing fresh serum and antibiotic-free RPMI 1640. The
mucosal surface was continually exposed to air.
Evaluation of curcumin cytotoxicity
Viability of the ex vivo porcine vaginal tissue explants was
quantified using Cell Growth Determination kit (Sigma, St. Louis,
MO). . Explants were incubated with various amounts of
curcumin (Sigma, St. Louis, MO) in 100% DMSO at 37uC, 7%
CO2 for 24 h. The effect of each formulation on tissue viability
was expressed relative to untreated tissue control. SDS was used as
a positive control for cytotoxicity (data not shown) [43].
Inhibition of IL-8 from ex vivo porcine vaginal tissue by
curcumin
Porcine vaginal explants (5 mm), (n=3 per treatment)were
exposed to curcumin (1.35–135 nmoles/explant) in 10% DMSO
for 6 h. In some experiments, tissue explants were exposed to
filtered (0.2 mm filter size) overnight S. aureus MNPE culture
supernates [containing SEC, TSST-1, and a-toxin [44], and no
live bacteria] for 1 h. Curcumin (13–135 nmoles/explant) in 10%
DMSO was then added to the explants. Following an additional
6 h incubation tissue explants were placed into 0.25 ml PBS and
vortexed at maximum speed for 2 min. This solution was clarified
by centrifugation (14,000 g for 2 min), and supernate was
removed and saved for IL-8 measurement via porcine specific
ELISA (R & D Systems, Minneapolis, MN) following manufac-
turer’s protocol.
Rabbit model of mTSS
Ethics statement. All animal studies were performed in
accordance with requirements established by the University of
Minnesota Institutional Animal Care and Use Committee
(IACUC), with specific approval given for this work under
protocol 0908A71722 (project name Staphylococcal
Superantigen Interactions With Vaginal Epithelium). A rabbit
vaginal mTSS model was used to determine the ability of
curcumin to inhibit TSST-1 induced proinflammatory effects on
vaginal mucosal with subsequent TSS and lethality in rabbits,
which was described elsewhere [26–28]. This model utilizes the
ability of superantigens to enhance shock caused by LPS from
Salmonella enterica serovar Typhimurium and causes mortality due
to TSS within 24 h. Rabbits were anesthetized with ketamine
(25 mg/kg; Phoenix Pharmaceuticals, Inc., St. Joseph, MO) and
xylazine (20 mg/kg; Phoenix Pharmaceuticals, Inc.) prior to
insertion of catheters into rabbit vaginas. TSST-1 (10 mg) was
administered vaginally in 0.2 ml in 3% DMSO with or without
curcumin (1.62 mmoles). LPS (0.1 mg/kg) was administered
intravenously in the marginal ear veins 4 h after instillation of
TSST-1. Additionally, 4 rabbits were given curcumin
(1.62 mmoles) alone to determine the effect of curcumin alone on
the rabbits. Rabbits were monitored for an additional 66 h.
Rabbits displaying signs of severe illness (failure to right themselves
and exhibit escape behavior), or those remaining healthy at the
conclusion of the experiment, were euthanized with Beuthanasia
D (1 ml/kg, Schering-Plough Animal Health Corp., Union, NJ)
according to the University of Minnesota Institutional Animal
Care and Use Committee requirement. Post mortem blood was
collected via cardiac puncture and allowed to clot in serum
collection tubes (BD Vacutainer, Franklin Lakes, NJ), and serum
was separated by centrifugation (1,000 g for 10 min) and stored at
220uC. Vaginal and liver tissues were removed and stored at
220uC.
TNF-a determination in rabbit serum and vaginal tissue
Vaginal tissue was placed in 0.25 ml PBS with 1% BSA and
0.05% Tween 20 and homogenized (three 20 s bursts at maximum
power). Homogenates were clarified by centrifugation (14,000 g
for 2 min). The clarified homogenates were stored at 220uC until
analysis. TNF-a was measured in serum and vaginal tissue using
rabbit specific ELISA (BD Bioscience, Franklin Lakes, NJ)
following the manufacturer’s protocol. For serum samples, the
lower limit of detection was 0.5 ng/ml and 0.125 ng/tissue section
in vaginal tissue.
Curcumin determination
Curcumin concentration in tissue was analyzed using a
previously established liquid chromatography-mass spectrometry
(LC-MS) assay [45]. Tissues were homogenized and lyophilized.
Curcumin was extracted from dry tissue using ethyl acetate (2 mL)
overnight. Extracts were evaporated under nitrogen stream and
Table 1. Primers used in reverse transcription polymerase
chain reaction.
Gene Primer Sequence
IL-8 Forward- 59 AGCCTTCCTGATTTCTGCAGCTCT
Reverse- 59 AATTTCTGTGTTGGCGCAGTGTGG
IL-6 Forward- 59 CATGTGTGAAAGCAGCAAGAGGC
Reverse- 59 CACCAGGCAAGTCTCCTCATTGAA
TNF-a Forward- 59 TGCCTGCTGCACTTTGGAGTGAT
Reverse- 59 GGTTCGAGAAGATGATCTGACTGCCT
MIP-3a Forward- 59 TTGCTCCTGGCTGCTTTGATGT
Reverse- 59 TGCCGTGTGAAGCCCACAATAA
HPRT Forward- 59 GGTGAAAAGGACCCCACGAA
Reverse- 59 AGTCAAGGGCATATCCTACA
doi:10.1371/journal.pone.0032813.t001
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on an Agilent Technologies (1200 series) system with negative ESI
connected to a TSQ Quantum system. An Agilent XDB-C18
1.8 mm, 4.6650 mm column was used for separation. Mobile
phase consisted of (A) 10 mM ammonium acetate and (B)
acetonitrile. Gradient flow (0.5 mL/min) with a total run time of
10 min was used: 0–4.5 min: 45–100% B, 4.5–5.5 min: 100% B,
5.5–6 min: 100-45% B, 6–10 min: 45% B. The following mass
transitions were monitored: curcumin - 367R216, hydroxybenzo-
phenone 197R92. The lower limit of quantification was
0.15 nmoles/tissue section or 0.15 nmoles/ml serum.To estimate
the total amount of curcumin within the tissue at late (70 h post
curcumin dose) time point, the following calculation was made:
Average curcumin concentration (nmoles/mg dry tissue
weight)69.1 mg tissue weight (average tissue section weight)64
(approximately 25% of total vaginal tissue was used for curcumin
determination)=estimated total vaginal curcumin.
Statistical analysis
Unless otherwise specified, significance was determined by one
way ANOVA using Dunnett’s multiple comparison test, compar-
ing experimental columns to control column (GraphPad Prism, La
Jolla, CA). Significance between curcumin- and untreated
mortality in rabbits was determined by Log-rank test.
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